Snyk vs BioCatch

By valuation, Snyk is the larger company at $7.4B versus $1.3B — a 5.7x difference. Size can also be measured by team: Snyk employs 2000 people while BioCatch has 100-500 employees.

Snyk has raised more in total funding at $1.3B, compared to BioCatch's $213M — a gap of $1.1B. Combined, the two companies have completed 9 known funding rounds.

Snyk leads with an Awaira Score of 82/100, while BioCatch sits at 80/100. That 2-point gap reflects real differences in funding, scale, and traction — it's not a vanity metric.

Snyk was founded by Guy Podjarny in 2015. BioCatch was founded by Avi Turgeman in 2011. Visit each company's profile on Awaira for a full founder biography.

Snyk: Snyk is a developer security platform founded in 2015 that specializes in identifying and fixing vulnerabilities in open-source dependencies, container images, and infrastructure-as-code. The company operates at the intersection of DevSecOps and AI, providing automated scanning and remediation tools integrated into development workflows. Snyk's core products include dependency scanning, container security, infrastructure-as-code scanning, and code analysis capabilities powered by machine learning and vulnerability intelligence databases. The platform integrates with popular development tools and CI/CD pipelines including GitHub, GitLab, Bitbucket, and Jenkins, enabling developers to identify security issues during development rather than post-deployment. With a valuation of $7.4 billion and total funding of $1.32 billion across Series G funding, Snyk has achieved significant growth in the expanding application security market. The company serves enterprise customers across multiple industries, addressing the critical challenge of securing software supply chains as organizations increasingly rely on open-source components. Snyk competes with companies including Sonatype, Aqua Security, and Anchore in the developer-first security space. The platform's approach emphasizes shifting security left in the development lifecycle, reducing remediation costs and time-to-fix vulnerabilities. Growth has been driven by increasing regulatory requirements, rising software supply chain attacks, and enterprise adoption of DevSecOps practices. Snyk uniquely positions security enforcement at the point of code development, enabling developers to fix vulnerabilities before deployment with AI-powered remediation guidance. BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection.

BioCatch got there first, launching in 2011 — that's 4 years of extra runway. Snyk didn't arrive until 2015. In AI, that kind of head start means more training data, deeper customer relationships, and a bigger talent moat.

Snyk has about 2000 employees; BioCatch has about 100-500. A bigger team usually means more revenue or heavier VC backing, but in AI, small teams can build at massive scale.

Yes — they're direct rivals. Both Snyk and BioCatch compete in AI Security, targeting many of the same buyers. If you're evaluating one, you should be looking at the other.